IN BRIEF: AstraZeneca prices EUR1.4 billion in bonds at 3.1% and 3.3%
AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Prices two tranches of eurobonds, raising a total of EUR1.40 billion for "general corporate purposes". Issues EUR650 million in fixed-rate notes with a coupon of 3.121% maturing in August 2030, and EUR750 million in fixed-rate notes with a coupon of 3.278% maturing in August 2033. The offering, by subsidiary AstraZeneca Finance LLC, is run by BNP Paribas, Goldman Sachs International, Morgan Stanley and Societe Genarale as joint book-running managers. Read More